China Health Industries Holdings Inc.

China Health Industries Holdings Inc. is a manufacturer and distributor specializing in health food products, pharmaceuticals, and health supplements. Through its subsidiaries, Harbin Humankind Biology Technology Co., Limited and Heilongjiang Huimeijia Pharmaceutical Co., Ltd., the company operates a GMP-certified facility with the capacity to produce 21 National Medical Products Administration (NMPA)-approved medicines, 14 approved health supplement products, and 8 hemp derivative offerings. These products are available in various forms, including soft and hard capsules, tablets, granules, and oral liquids, catering to diverse consumer segments such as women, seniors, and children. China Health Industries Holdings Inc. primarily serves the Chinese market, addressing both preventive health and wellness needs alongside traditional pharmaceutical demands. The company’s position in the health food and pharmaceutical industry reflects its role in supporting public health initiatives and consumer health trends within China’s regulated healthcare sector.